APIs and Excipients

Austrian Centre of Industrial Biotechnology and GE Healthcare Form Cell Line Engineering Pact

February 07, 2017

This three-year partnership will explore and identify new tools and methods to modify and optimize the Chinese hamster ovary (CHO) cell line performance.

Reducing the Cost of Goods and Environmental Impact

February 02, 2017

Collaboration Key to Meeting Excipient GMP Requirements

February 02, 2017

Drug manufacturers need to work closely with excipient suppliers to ensure supply chain safety.

PTSM: Pharmaceutical Technology Sourcing and Management

New Drug Approvals Slump in 2016

February 01, 2017

FDA issued approvals for less than half the number of new drugs in 2016 compared with 2015.

Johnson Matthey Launches Online Catalyst Store

January 13, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

New website allows access to research quantities of commercial-grade ligands and catalysts.

PTSM: Pharmaceutical Technology Sourcing and Management

New Catalysts Enable Cross-Coupling Reactions

January 04, 2017

Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.

FDA New Drug Approvals Down Significantly in 2016

January 02, 2017

As of mid-December, less than half the number of new drug approvals were issued by FDA in 2016 compared with 2015.

AGC Asahi Glass Acquires CMC Biologics

December 21, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.

Oxford Genetics Receives Grant from Innovate UK

December 15, 2016

Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.

Saneca Invests in API Manufacturing R&D

December 09, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Saneca Pharma has received a EUR1.5 million grant from the Slovak Ministry of Education, Science, Research, and Sport, which will be used to drive forward new R&D initiatives for API manufacturing.